What a prescriber is looking for in a weight-loss assessment
What does a prescriber actually check in a weight-loss assessment?
A prescriber is checking three things: whether anything rules treatment out entirely, whether you meet the clinical threshold, and whether anything you already take or already have changes the risk. Since the GPhC added weight-management medicines to its high-risk list, they are also required to independently verify your height, weight and BMI rather than accept a form — so the assessment is a safeguard rather than a gate, and the questions that look like obstacles are the ones doing the work.
It is not a test you pass
Most writing about weight-loss assessments frames them as a hurdle: here is what you need to qualify, here is how to get through. That framing is understandable and it is the wrong way round.
An assessment exists to find the people for whom a medicine is a bad idea. Everything else it does is secondary. The questions that feel like obstacles — the ones about your family history, your gallbladder, your previous reactions — are not gatekeeping. They are the entire clinical purpose of the exercise, and a service that asks fewer of them is not being more convenient. It is doing less for you.
The useful consequence is that you have nothing to gain from presenting well. A prescriber who declines has given you a real answer about a real medicine. A prescriber who approves everyone has told you nothing at all.
Why a questionnaire on its own is no longer allowed
The General Pharmaceutical Council, which regulates pharmacies in Great Britain, has added medicines used for weight management to the category it treats as high risk. The practical effect is specific: for a high-risk medicine, a prescriber cannot base the decision on what an online questionnaire says.
They have to independently verify the information. The guidance names the routes — timely two-way communication with you, access to your clinical records, or contact with your GP, your regular prescriber or another provider — and for weight-management medicines in particular it names the fields: your height, your weight, and your BMI.
This is worth understanding before you start, because it changes what a good service looks like. If a site takes a form, takes a payment, and ships a pen without anyone verifying anything, that is not an efficient service. It is one operating outside the guidance its regulator published, and the thing being skipped is the part that protects you.
The questions that rule treatment out
Some answers end the conversation, and they are the ones worth understanding before you are asked.
- Medullary thyroid cancer, personal or familyA personal or family history of medullary thyroid carcinoma is a contraindication for this class. "Family" means it, and it is asked because the relevant history may be a relative's rather than your own.
- Multiple endocrine neoplasia type 2MEN2 is an inherited syndrome that carries a high lifetime risk of medullary thyroid cancer, and it is excluded for the same reason.
- Pregnancy, or trying to conceiveThese medicines are not used in pregnancy. If you are pregnant, planning to be, or breastfeeding, that is a stop rather than a caution — and it is also worth raising if your contraception could be affected.
- Previous pancreatitisA history of acute pancreatitis is in most cases a contraindication, and it needs to be disclosed even if it was years ago and resolved completely.
- A previous reaction to this classA significant adverse reaction to a GLP-1 medicine before is relevant whichever brand it was, because the mechanism is shared.
The threshold, and why your numbers get checked
Eligibility in the UK is built on BMI with a comorbidity adjustment: a higher BMI on its own, or a lower one where a weight-related condition is present. The thresholds are not arbitrary and they are not ours — they follow national guidance, and a service setting its own lower bar is not being generous.
What has changed is that your numbers are now verified rather than accepted. That is the GPhC requirement described above, and it exists because a self-reported height and weight is the easiest thing in the world to adjust by the few kilograms that move someone across a threshold.
If you are close to a threshold, say so plainly rather than rounding. The conversation about whether treatment is appropriate for someone near the boundary is a real clinical conversation. The conversation that follows a number nobody can verify is a different and worse one.
What else you take, and what else you have
A prescriber will ask for every medicine you take, including ones you would not think to mention: over-the-counter painkillers, supplements, herbal remedies, anything prescribed by someone else for something unrelated.
The reason is that these medicines slow gastric emptying, which is part of how they work and also changes how other things are absorbed. Oral contraception is the example worth raising yourself if it applies to you. Insulin and sulfonylureas matter because the combination affects blood glucose. Any history of gallbladder disease, severe reflux, or an eating disorder changes the picture in ways a questionnaire will ask about but a conversation handles better.
None of these is automatically disqualifying. All of them change what a careful prescriber does next — a slower titration, a different starting point, a referral, or a question put to your GP.
Why withholding something works against you
It is worth being blunt about the incentive here, because the temptation is obvious and the logic behind it does not hold.
If you omit a condition and are approved, you have not won access to a treatment. You have obtained a medicine whose risk profile was calculated without the fact that mattered most. The prescriber's decision was sound given what they were told; it was simply not about you.
The second reason is practical. Independent verification means a prescriber may be looking at your clinical record or speaking to your GP. An omission is likely to surface, and when it surfaces mid-treatment it is handled worse than it would have been at the start.
What to have ready
An assessment goes better with five minutes of preparation, and none of it requires anything you do not already have.
- An accurate height and weightMeasured rather than remembered. These are the figures that get verified.
- Your current medicinesThe actual names and doses. A photograph of the boxes is faster than trying to recall them.
- Your conditions, including the dormant onesAnything diagnosed, even if it is controlled, resolved or you no longer think about it.
- What you have already triedPrevious treatments, how they went, and why they stopped. This changes what is sensible to try next.
- Your family history, where you know itSpecifically thyroid cancer and endocrine conditions. If you do not know, say you do not know rather than guessing.
- Your questionsAn assessment is two-way. What you want to ask is part of it, not an interruption to it.
Common questions
Can I be prescribed weight-loss medication from an online form alone?
Not under current GPhC guidance. Weight-management medicines are treated as high risk, which means a prescriber cannot base the decision on an online questionnaire by itself and has to independently verify what you have reported — including your height, weight and BMI — through two-way contact, your clinical records, or your GP. A service that supplies without any of that is not following the guidance its regulator published.
What happens if I am declined?
You should be told why, and the reason should be specific. A decline is a clinical finding rather than a verdict on you: it may be an absolute contraindication, a threshold you do not currently meet, or something that needs investigating first. In many cases it points at a different route rather than closing the subject.
Will my GP be told?
With your consent, a prescriber may contact your GP — and for a high-risk medicine that is one of the routes the guidance names for verifying what you have reported. Keeping the person who manages the rest of your care informed is also simply good practice when you start a medicine that affects appetite, blood glucose and the absorption of other drugs.
Does a family history of thyroid cancer definitely rule me out?
A personal or family history of medullary thyroid carcinoma, and the inherited syndrome MEN2, are contraindications for this class of medicine. Thyroid cancer is not one disease, so the specific type matters — which is why the question is asked precisely rather than generally, and why it is worth finding out the detail if you can.
How long does an assessment take?
The questionnaire part is short. The whole process takes longer because verification is a separate step, and because a prescriber reviewing your answers is not the same as a form being scored. If a service completes the entire thing in moments, the verification step is the one that has been left out.
Sources
- Online pharmacies to strengthen safeguards to prevent unsafe supply of medicines · General Pharmaceutical Council
- Weight loss medications — what to expect from a pharmacy service · General Pharmaceutical Council
- Mounjaro KwikPen — Summary of Product Characteristics · electronic medicines compendium
- Wegovy FlexTouch solution for injection — Summary of Product Characteristics · electronic medicines compendium
- Obesity: identification, assessment and management (CG189) · NICE
Calum Polwart
Pharmacist Independent Prescriber and Supplementary Prescriber
Last updated
Related
Every clinical claim on this site is sourced and dated.
Blog